ClinicalTrials.govpublic full text
A Phase II Study of a Combination of MTA (LY231514) and Gemcitabine in Patients With Metastatic Breast Cancer.
breast neoplasms, metastatic breast cancer, combination therapy, alimta, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 852329
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.